Surface Oncology, Inc. Net Profit Margin 2018-2023 | SURF
Surface Oncology, Inc. net profit margin from 2018 to 2023. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2022-03-31 | $0.03B | $-0.06B | -183.87% |
| 2021-12-31 | $0.00B | $-0.08B | -2633.33% |
| 2021-09-30 | $0.09B | $0.01B | 13.19% |
| 2020-12-31 | $0.13B | $0.06B | 46.46% |
| 2020-03-31 | $0.04B | $-0.03B | -71.79% |
| 2019-12-31 | $0.01B | $-0.06B | -392.86% |
| 2019-09-30 | $0.02B | $-0.02B | -70.83% |
| 2019-06-30 | $0.03B | $-0.02B | -65.38% |
| 2019-03-31 | $0.03B | $-0.02B | -53.57% |
| 2018-12-31 | $0.06B | $-0.01B | -11.86% |
| 2018-09-30 | $0.05B | $-0.05B | -88.24% |
| 2018-06-30 | $0.05B | $-0.04B | -82.35% |
| 2018-03-31 | $0.06B | $-0.03B | -60.00% |
| 2017-12-31 | $0.01B | $-0.05B | -383.33% |
